These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27070955)

  • 1. Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.
    Kumar M; Yadav AK; Verma V; Singh B; Mal G; Nagpal R; Hemalatha R
    Future Microbiol; 2016; 11(4):585-600. PubMed ID: 27070955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered microbes in disease therapy.
    Paton AW; Morona R; Paton JC
    Trends Mol Med; 2012 Jul; 18(7):417-25. PubMed ID: 22721939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing and genetic engineering approaches for advanced probiotics: A review.
    Yadav R; Kumar V; Baweja M; Shukla P
    Crit Rev Food Sci Nutr; 2018 Jul; 58(10):1735-1746. PubMed ID: 28071925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in human health and disease: from nutribiotics to pharmabiotics.
    Lee ES; Song EJ; Nam YD; Lee SY
    J Microbiol; 2018 Nov; 56(11):773-782. PubMed ID: 30353462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases.
    Debnath N; Yadav P; Mehta PK; Gupta P; Kumar D; Kumar A; Gautam V; Yadav AK
    Biotechnol Bioeng; 2024 Jan; 121(1):100-117. PubMed ID: 37881101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced probiotics: bioengineering and their therapeutic application.
    Parvin T; Sadras SR
    Mol Biol Rep; 2024 Feb; 51(1):361. PubMed ID: 38403783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.
    Cano-Garrido O; Seras-Franzoso J; Garcia-Fruitós E
    Microb Cell Fact; 2015 Sep; 14():137. PubMed ID: 26377321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Diagnostic and Therapeutic Gut Bacteria.
    Landry BP; Tabor JJ
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered probiotics, a strategic approach to control enteric infections.
    Amalaradjou MA; Bhunia AK
    Bioengineered; 2013; 4(6):379-87. PubMed ID: 23327986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics: overview of microbiological and immunological characteristics.
    Blandino G; Fazio D; Di Marco R
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):497-508. PubMed ID: 18662116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
    Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
    Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive interactions with the microbiota: probiotics.
    Kalliomäki M; Salminen S; Isolauri E
    Adv Exp Med Biol; 2008; 635():57-66. PubMed ID: 18841703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Probiotics: Applications and Biological Containment.
    Sola-Oladokun B; Culligan EP; Sleator RD
    Annu Rev Food Sci Technol; 2017 Feb; 8():353-370. PubMed ID: 28125354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of probiotics for disorders of the brain-gut axis.
    Quigley EM; Shanahan F
    Adv Exp Med Biol; 2014; 817():417-32. PubMed ID: 24997045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant probiotics with antimicrobial peptides: a dual strategy to improve immune response in immunocompromised patients.
    Mandal SM; Silva ON; Franco OL
    Drug Discov Today; 2014 Aug; 19(8):1045-50. PubMed ID: 24881782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered pharmabiotics with improved therapeutic potential.
    Sleator RD; Hill C
    Hum Vaccin; 2008; 4(4):271-4. PubMed ID: 18682694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles and technological requirements of urogenital probiotics.
    Nader-Macías ME; Juárez Tomás MS
    Adv Drug Deliv Rev; 2015 Sep; 92():84-104. PubMed ID: 25858665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial munch for infants: potential pediatric therapeutic interventions of probiotics.
    Khurshid M; Aslam B; Nisar MA; Akbar R; Rahman H; Khan AA; Rasool MH
    Future Microbiol; 2015; 10(11):1881-95. PubMed ID: 26515509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Related actions of probiotics and antibiotics on gut microbiota and weight modification.
    Angelakis E; Merhej V; Raoult D
    Lancet Infect Dis; 2013 Oct; 13(10):889-99. PubMed ID: 24070562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.